谷实生物 (838651.OC)

+ 收藏

现金流量表(谷实生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年年报2023年中报2022年年报2022年中报
上市前/上市后 上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表
一、经营活动产生的现金流量
 销售商品、提供劳务收到的现金(元) 3,770,086,720.251,666,640,109.183,354,929,801.261,380,923,395.61
 收到的税费返还(元) -4,110,137.71-2,452,226.88
 收到其他与经营活动有关的现金(元) 78,997,292.3439,222,604.0046,334,771.7820,354,187.00
 经营活动现金流入小计(元) 3,849,084,012.591,709,972,850.893,401,264,573.041,403,729,809.49
 购买商品、接受劳务支付的现金(元) 3,505,066,339.651,684,005,237.643,016,031,986.811,316,925,446.53
 支付给职工以及为职工支付的现金(元) 127,920,066.5567,547,452.10107,766,385.7856,678,031.44
 支付的各项税费(元) 18,637,435.7112,765,547.0513,312,718.108,026,297.37
 支付其他与经营活动有关的现金(元) 115,466,326.3440,351,577.0072,383,442.2622,583,635.45
 经营活动现金流出小计(元) 3,767,090,168.251,804,669,813.793,209,494,532.951,404,213,410.79
 经营活动产生的现金流量净额(元) 81,993,844.34-94,696,962.90191,770,040.09-483,601.30
二、投资活动产生的现金流量
 收回投资收到的现金(元) 505,068,725.31394,200,000.001,295,410,000.00497,210,000.00
 取得投资收益收到的现金(元) 664,336.55646,281.071,508,487.72677,585.37
 处置固定资产、无形资产和其他长期资产收回的现金净额(元) 2,055,570.44-1,671,500.0026,500.00
 投资活动现金流入小计(元) 507,788,632.30394,846,281.071,298,589,987.72497,914,085.37
 购建固定资产、无形资产和其他长期资产支付的现金(元) 118,914,569.2228,055,934.2884,386,531.3439,078,646.68
 投资支付的现金(元) 504,200,000.00394,200,000.001,298,955,661.59499,168,474.09
 投资活动现金流出小计(元) 623,114,569.22422,255,934.281,383,342,192.93538,247,120.77
 投资活动产生的现金流量净额(元) -115,325,936.92-27,409,653.21-84,752,205.21-40,333,035.40
三、筹资活动产生的现金流量
 吸收投资收到的现金(元) 7,350,000.001,000,000.00--
  其中:子公司吸收少数股东投资收到的现金(元) 7,350,000.001,000,000.00--
 取得借款收到的现金(元) 428,000,000.00212,000,000.00194,285,000.0077,285,000.00
 收到其他与筹资活动有关的现金(元) 5,000,000.00-11,998,208.00-
 筹资活动现金流入小计(元) 440,350,000.00213,000,000.00206,283,208.0077,285,000.00
 偿还债务支付的现金(元) 382,484,092.83165,746,000.00122,005,000.0017,885,000.00
 分配股利、利润或偿付利息支付的现金(元) 91,730,208.397,514,741.52111,984,236.4328,341,541.01
 支付其他与筹资活动有关的现金(元) 25,192,389.324,203,902.149,125,862.991,138,631.00
 筹资活动现金流出小计(元) 499,406,690.54177,464,643.66243,115,099.4247,365,172.01
 筹资活动产生的现金流量净额(元) -59,056,690.5435,535,356.34-36,831,891.4229,919,827.99
五、现金及现金等价物净增加额(元) -92,388,783.12-86,571,259.7770,185,943.46-10,896,808.71
 加:期初现金及现金等价物余额(元) 158,223,062.02158,223,062.0288,037,118.5688,037,118.56
 期末现金及现金等价物余额(元) 65,834,278.9071,651,802.25158,223,062.0277,140,309.85
补充资料:
 净利润(元) 34,801,623.6433,956,509.20231,047,171.7763,817,402.00
 资产减值准备(元) 24,547,036.55-4,723,809.6465,716,721.42208,385.82
 固定资产和投资性房地产折旧(元) 68,803,793.0732,745,252.0157,570,924.0226,748,444.33
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧(元) 68,803,793.0732,745,252.0157,570,924.0226,748,444.33
 无形资产摊销(元) 1,184,800.44592,400.221,184,800.44592,400.22
 长期待摊费用摊销(元) 1,168,244.91510,960.31914,718.12442,659.01
 处置固定资产、无形资产和其他长期资产的损失(元) -430,510.7411,067,878.70-13,721.9416,664,600.01
 固定资产报废损失(元) 4,994,326.5116,391.762,605,392.1816,957.47
 财务费用(元) 13,262,308.156,058,041.8814,473,603.956,632,834.58
 投资损失(元) -1,533,061.86-546,889.522,036,843.77-677,585.37
 递延所得税(元) -1,781,942.22234,894.15-262,985.83661,086.25
  其中:递延所得税资产减少(元) 424,620.05354,045.48-2,968,882.52263,529.27
 递延所得税负债增加(元) -2,206,562.27-119,151.332,705,896.69397,556.98
 存货的减少(元) -153,571,493.16-155,844,105.15-184,167,740.31-110,164,419.45
 经营性应收项目的减少(元) 9,347,097.87-5,136.21-62,563,093.37-23,873,057.21
 经营性应付项目的增加(元) 69,678,600.22-23,500,375.4456,701,313.0514,390,087.13
 现金的期末余额(元) 65,834,278.9071,651,802.25158,223,062.0277,140,309.85
 减:现金的期初余额(元) 158,223,062.02158,223,062.0288,037,118.5688,037,118.56
 现金及现金等价物的净增加额(元) -92,388,783.12-86,571,259.7770,185,943.46-10,896,808.71
公告日期 2024-04-262023-08-292023-04-272022-08-30
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院